Effect of DNA polymerase on nuclei from different phases of cell cycle.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 4474940)

Published in Eur J Biochem on December 02, 1974

Authors

O Bernard, R L Momparler, T P Brent

Articles by these authors

Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature (1998) 7.76

Sequences of mouse immunoglobulin light chain genes before and after somatic changes. Cell (1978) 7.53

Sequence of a mouse germ-line gene for a variable region of an immunoglobulin light chain. Proc Natl Acad Sci U S A (1978) 6.80

Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. EMBO J (1983) 5.93

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia (2009) 4.53

Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron (2001) 3.47

Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (1991) 2.67

Sequences of the joining region genes for immunoglobulin heavy chains and their role in generation of antibody diversity. Proc Natl Acad Sci U S A (1981) 2.38

Partial purification and properties of two forms of deoxyribonucleic acid polymerase from calf thymus. J Biol Chem (1973) 2.31

Two forms of the basic fibroblast growth factor receptor-like mRNA are expressed in the developing mouse brain. Proc Natl Acad Sci U S A (1990) 2.17

Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A (1998) 2.17

Effect of cytosine arabinoside 5'-triphosphate on mammalian DNA polymerase. Biochem Biophys Res Commun (1969) 2.16

Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors. Proc Natl Acad Sci U S A (1982) 2.16

Phosphorylation of ADF/cofilin abolishes EGF-induced actin nucleation at the leading edge and subsequent lamellipod extension. J Cell Biol (2000) 2.10

Nucleotide sequence of immunoglobulin heavy chain joining segments between translocated VH and mu constant regions genes. Proc Natl Acad Sci U S A (1980) 2.06

Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome. Gastroenterology (1999) 2.06

The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology (2001) 1.99

Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin. J Biol Chem (2001) 1.93

bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene (1996) 1.87

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology (1988) 1.79

Methylation hot spots in the 5' flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene. Cancer Res (1997) 1.77

Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood (1993) 1.74

Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. Cancer Res (1976) 1.70

Variations in phosphokinase activities during the cell cycle in synchronous populations of HeLa cells. Nature (1965) 1.61

Autoimmune hepatitis with initial presentation as acute hepatic failure in young children. J Pediatr (1990) 1.61

A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein. EMBO J (1997) 1.60

Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation (2001) 1.59

Spontaneous perforation of the biliary tract in infancy: a series of 11 cases. Eur J Pediatr Surg (1996) 1.58

Transient neonatal cholestasis: origin and outcome. J Pediatr (1998) 1.53

Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum. J Exp Med (1985) 1.52

Current lifestyle of young adults after liver transplantation during childhood. Am J Transplant (2010) 1.51

Human lymphoblasts contain DNA glycosylase activity excising N-3 and N-7 methyl and ethyl purines but not O6-alkylguanines or 1-alkyladenines. Proc Natl Acad Sci U S A (1981) 1.50

NTBC treatment in tyrosinaemia type I: long-term outcome in French patients. J Inherit Metab Dis (2008) 1.48

A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine. Cancer Res (1974) 1.48

Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke. J Neurosci (2001) 1.46

Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology (1996) 1.41

Organization of genes and spacers within the mouse immunoglobulin VH locus. J Mol Appl Genet (1981) 1.41

Incidence of cirrhosis in children with chronic hepatitis. J Pediatr (1990) 1.41

False-positive result of hepatitis C enzyme-linked immunosorbent assay in children with autoimmune hepatitis. J Pediatr (1991) 1.40

Portal obstruction in children. I. Clinical investigation and hemorrhage risk. J Pediatr (1983) 1.40

TEL is a sequence-specific transcriptional repressor. J Biol Chem (1999) 1.39

Repair of alkylated DNA in mammalian cells. Nature (1968) 1.38

Incorporation of 5-Aza-2'-deoxycytidine-5'-triphosphate into DNA. Interactions with mammalian DNA polymerase alpha and DNA methylase. Mol Pharmacol (1983) 1.37

Unusual early presentation of Gilbert syndrome in pediatric recipients of liver transplantation. J Pediatr Gastroenterol Nutr (2000) 1.37

Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models. Clin Cancer Res (2000) 1.35

Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector. Mol Ther (2001) 1.33

Cholelithiasis in infancy: a study of 40 cases. J Pediatr (1993) 1.31

Outcome of liver disease in children with Alagille syndrome: a study of 163 patients. Gut (2001) 1.29

Social stress exacerbates stroke outcome by suppressing Bcl-2 expression. Proc Natl Acad Sci U S A (2001) 1.29

The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers. Clin Pharmacol Ther (2007) 1.28

mRNA for surface immunoglobulin gamma chains encodes a highly conserved transmembrane sequence and a 28-residue intracellular domain. Proc Natl Acad Sci U S A (1982) 1.28

Long-term follow-up of growth in height after successful liver transplantation. J Pediatr (1994) 1.28

Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models. Clin Cancer Res (2000) 1.27

TEL-JAK2 transgenic mice develop T-cell leukemia. Blood (2000) 1.26

Portal obstruction in children. II. Results of surgical portosystemic shunts. J Pediatr (1983) 1.26

Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology (1997) 1.25

Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside. Biochem Pharmacol (1983) 1.24

Congenital hepatic fibrosis in children. J Pediatr (1981) 1.24

Plasmacytomas with more than one immunoglobulin kappa mRNA: implications for allelic exclusion. Proc Natl Acad Sci U S A (1981) 1.24

A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene (1995) 1.23

The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. Blood (1995) 1.22

Pulmonary arteriovenous shunting in children with liver disease. J Pediatr (1995) 1.22

Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediatr (1981) 1.20

Liver disease associated with anti-liver-kidney microsome antibody in children. J Pediatr (1986) 1.19

Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene. Nucleic Acids Res (1991) 1.19

Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action. Cancer Res (1983) 1.19

bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci U S A (1995) 1.18

Organization and expression of murine immunoglobulin genes. Immunol Rev (1981) 1.17

Transport of nucleosides. Ann N Y Acad Sci (1975) 1.17

Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily. J Exp Med (1988) 1.16

Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr (1993) 1.15

O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts. J Neurosurg (1989) 1.15

Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase. Biochem Pharmacol (1993) 1.15

Immortalization of mouse neural precursor cells by the c-myc oncogene. Proc Natl Acad Sci U S A (1988) 1.15

Phase I study on 5-aza-2'-deoxycytidine in children with acute leukemia. Leuk Res (1981) 1.15

Partial purification and characterization of 3-methyladenine-DNA glycosylase from human placenta. Biochemistry (1982) 1.14

DNA replication in isolated HeLa cell nuclei. Biochem Biophys Res Commun (1973) 1.14

1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O6-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition. Cancer Chemother Pharmacol (2003) 1.12

Deoxyribonucleoside 5'-triphosphate pool fluctuations during the mammalian cell cycle. Biochim Biophys Acta (1972) 1.11

Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway. Oncogene (2001) 1.11

Suppression of cross-link formation in chloroethylnitrosourea-treated DNA by an activity in extracts of human leukemic lymphoblasts. Cancer Res (1984) 1.11

Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc Natl Acad Sci U S A (1998) 1.11

Properties of a human lymphoblast AP-endonuclease associated with activity for DNA damaged by ultraviolet light, gamma-rays, or osmium tetroxide. Biochemistry (1983) 1.11

Bacterial cholangitis after surgery for biliary atresia. J Pediatr (1987) 1.10

Implication of Bcl-2 and Caspase-3 in age-related Purkinje cell death in murine organotypic culture: an in vitro model to study apoptosis. Eur J Neurosci (2000) 1.10

A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin. Leukemia (2008) 1.08

Repair enzyme suggested by mammalian endonuclease activity specific for ultraviolet-irradiated DNA. Nat New Biol (1972) 1.08

Molecular, cellular and animal pharmacology of 5-aza-2'-deoxycytidine. Pharmacol Ther (1985) 1.08

1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity. Cancer Chemother Pharmacol (2003) 1.08

GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene. Oncogene (1994) 1.08

Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase. Cancer Chemother Pharmacol (1992) 1.07

Clinical trial on 5-aza-2'-deoxycytidine in patients with acute leukemia. Pharmacol Ther (1985) 1.07

Cytoplasmic sequestration of an O6-methylguanine-DNA methyltransferase enhancer binding protein in DNA repair-deficient human cells. Proc Natl Acad Sci U S A (1997) 1.07

Partial purification and characterization of a human 3-methyladenine-DNA glycosylase. Biochemistry (1979) 1.07

A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers. Mol Carcinog (1999) 1.07

Mammalian deoxynucleoside kinase. I. Deoxycytidine kinase: purification, properties, and kinetic studies with cytosine arabinoside. J Biol Chem (1968) 1.06

Anti-liver-kidney microsome antibody type 1 recognizes human cytochrome P450 db1. Biochem Biophys Res Commun (1989) 1.05

Isolation and purification of O6-alkylguanine-DNA alkyltransferase from human leukemic cells. Prevention of chloroethylnitrosourea-induced cross-links by purified enzyme. Pharmacol Ther (1985) 1.05

A new cause of progressive intrahepatic cholestasis: 3 beta-hydroxy-C27-steroid dehydrogenase/isomerase deficiency. J Pediatr (1994) 1.04